Balyasny Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-53,042
| Closed | -$2.71M | – | 1998 |
|
|
2024
Q3 | $2.71M | Sell |
53,042
-61,595
| -54% | -$3.15M | ﹤0.01% | 1047 |
|
|
2024
Q2 | $5.13M | Buy |
+114,637
| New | +$5.13M | 0.01% | 811 |
|
|
2023
Q3 | – | Sell |
-29,089
| Closed | -$524K | – | 1832 |
|
|
2023
Q2 | $524K | Buy |
+29,089
| New | +$524K | ﹤0.01% | 1452 |
|
|
2023
Q1 | – | Sell |
-744
| Closed | -$13.6K | – | 2269 |
|
|
2022
Q4 | $13.6K | Buy |
+744
| New | +$13.6K | ﹤0.01% | 2087 |
|